Name | Telomeric repeat-binding factor 2-interacting protein 1 | ||
UniProt ID | TE2IP_HUMAN | ||
Gene Name | TERF2IP | ||
Gene ID | 54386 | ||
Synonyms |
TERF2IP, DRIP5, RAP1
|
||
Sequence |
MAEAMDLGKDPNGPTHSSTLFVRDDGSSMSFYVRPSPAKRRLSTLILHGGGTVCRVQEPG
AVLLAQPGEALAEASGDFISTQYILDCVERNERLELEAYRLGPASAADTGSEAKPGALAE GAAEPEPQRHAGRIAFTDADDVAILTYVKENARSPSSVTGNALWKAMEKSSLTQHSWQSL KDRYLKHLRGQEHKYLLGDAPVSPSSQKLKRKAEEDPEAADSGEPQNKRTPDLPEEEYVK EEIQENEEAVKKMLVEATREFEEVVVDESPPDFEIHITMCDDDPPTPEEDSETQPDEEEE EEEEKVSQPEVGAAIKIIRQLMEKFNLDLSTVTQAFLKNSGELEATSAFLASGQRADGYP IWSRQDDIDLQKDDEDTREALVKKFGAQNVARRIEFRKK |
||
Pathway Map | MAP LINK | ||
KEGG ID | hsa54386 | ||
Pfam | PF08914; PF11626; PF13581; PF16589; PF17484 |
Pair Name | Tanshinone I, Lenalidomide | |||
Phytochemical | Tanshinone I | |||
Drug | Lenalidomide | |||
Disease Info | [ICD-11: 2A83] | Multiple myeloma | Investigative | |
Regulate Info | Down-regulation | Telomeric repeat-binding factor 2-interacting protein 1 | Expression | |
Result | Combination of TanI with standard chemotherapeutic drug Len, potentiates cell death in myeloma cells |
No. | Title | Href |
---|---|---|
1 | Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules. Mol Biol Rep. 2018 Dec;45(6):2429-2439. doi: 10.1007/s11033-018-4409-z. | Click |